Search ARM

Vascugen is a regenerative medicine company engaged in the development of induced-pluripotent stem cell (iPSC)-manufactured vasculogenic cell therapies to treat incurable conditions caused by loss or degeneration of blood vessels. Applications of the technology include functional restoration of blood vessels in ischemic tissues, payload delivery, and tissue engineering. Driven by innovation and a team of scientific and clinical thought leaders, Vascugen was co-founded by Dr. Mervin C. Yoder, a pioneer and noted expert in the field of vascular stem cell biology.

Contact Vascugen
Visit Website